Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation
Authors:
- Yi-Hung TsaiYTYi-Hung Tsai
- Wan-Chiech YangWYWan-Chiech Yang
- Jui-Sheng ChangJCJui-Sheng Chang
- Pao-Chu WuPWPao-Chu Wu
- Kozo TakayamaKTKozo Takayama
- 1 November 2004
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 58 (3) , 607-614
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Influence of formulation variables and manufacturing process on propranolol extended release profile from HPMC matrices tabletsJournal of Applied Polymer Science, 2004
- Once‐a‐Day Controlled‐Release Dosage form of Divalproex Sodium I: Formulation Design and in Vitro/in Vivo InvestigationsJournal of Pharmaceutical Sciences, 2003
- The Role of Intra- and Extragranular Microcrystalline Cellulose in Tablet DissolutionPharmaceutical Development and Technology, 1996
- Factorial design in the feasibility of producing Microcel MC 101 pellets by extrusion/spheronizationInternational Journal of Pharmaceutics, 1995
- In Vitro and in Vivo Correlation for Controlled-Release Formulation of d-Chlorpheniramine Maleate.Journal of Pharmacobio-Dynamics, 1991
- Novel computer optimization methodology for pharmaceutical formulations investigated by using sustained-release granules of indomethacin.Chemical and Pharmaceutical Bulletin, 1989
- Influence of surfactants on drug release from hydroxypropylmethylcellulose matricesInternational Journal of Pharmaceutics, 1988
- A simple equation for description of solute release II. Fickian and anomalous release from swellable devicesJournal of Controlled Release, 1987
- In vivo evaluation of ethyl cellulose microcapsules containing ampicillin using rabbits, beagle dogs and humans.Journal of Pharmacobio-Dynamics, 1986
- Kinetic Analysis of Blood Levels and Urinary Excretion in the Absorptive Phase after Single Doses of DrugJournal of Pharmaceutical Sciences, 1964